Second prostate-specific membrane antigen PET scan can change treatment for nearly half of

Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients. A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear Medicine.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear Medicine. Findings from the repeat PSMA scans, which included both local and distant disease, resulted in a change in management for nearly 50% of these patients.

• Ponto de atenção: second.
• Ponto de atenção: prostate.
• Ponto de atenção: specific.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.